Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Am J Transplant. 2020 Sep 15;21(1):314–321. doi: 10.1111/ajt.16277

TABLE 1.

Selected characteristics of (a) waitlisted and (b) transplanted patients among all referred and waitlisted patients with ESRD, respectively, in transplant programs of GA, NC, and SC: 2012–2015

Among patients referred to treatment programs in GA, NC, and SC between 2012 and 2015 N = 24 325
Among patients waitlisted in Tx-programs in GA, NC and SC between 2012 and 2015 N = 7174
Characteristic N (%) Waitlisted between 2012 and 2016 N = 7538 (31.0%) Transplanted between 2012 and 2016 N = 1320 (18.4%)
Mean age, y (SD) 50.3 (13.2) 49.9 (13.5)
Age category, y
 18–29 616 (8.2) 123 (9.3)
 30–39 1017 (13.5) 195 (14.8)
 40–49 1755 (23.3) 261 (19.8)
 50–59 2011 (26.7) 374 (28.3)
 60–69 1768 (23.5) 300 (22.7)
 70–80 371 (4.9) 67 (5.1)
Male sex, N (%) 4527 (60.1) 759 (57.5)
Black race, N (%) 4294 (58.3) 697 (54.0)
Comorbidities, N (%)
 Obesity (BMI ≥35 kg/m2) 1440 (19.7) 214 (16.7)
 Congestive heart failure 813 (10.8) 128 (9.7)
 Atherosclerotic heart disease 321 (4.3) 47 (3.6)
 Other cardiac disease 608 (8.1) 93 (7.1)
 Cerebrovascular disease (stroke) 1267 (16.8) 196 (14.9)
 Peripheral vascular disease 245 (3.3) 34 (2.6)
 Hypertension 6646 (88.2) 1153 (87.4)
 Diabetes 3208 (42.6) 500 (37.9)
 Chronic obstructive pulmonary disease 99 (1.3) 20 (1.5)
 Cancer 197 (2.6) 30 (2.3)
 Tobacco use 293 (4.0) 63 (4.9)
Primary health insurance provider, N (%)
 Medicare 1688 (22.9) 279 (21.7)
 Medicaid 1037 (14.1) 194 (15.1)
 Employer group 2637 (35.8) 455 (35.3)
 Other coverage 1000 (13.6) 170 (13.2)
 No coverage 1004 (13.6) 190 (14.8)